RecruitingNCT06189079

Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study

Embolizzazione Arteriosa Per il Trattamento Delle Metastasi Ossee: Studio Osservazionale Prospettico

Sponsor

Istituto Ortopedico Rizzoli

Enrollment

60 participants

Start Date

May 10, 2023

Study Type

OBSERVATIONAL

Conditions

Bone Metastases

Summary

To date, arterial embolization constitutes one of the most popular methods in minimally invasive treatment of bone metastases, allowing good results in terms of pain reduction, local control of disease and reduction of peri-operative bleeding, with low invasiveness.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Patients of either sex of age or older who are candidates for embolization therapy
Life expectancy > 3 months
Single metastatic or oligometastatic.
Plurimetastatic if a particular site is causing painful symptoms or at risk for pathologic rupture

Exclusion Criteria4

Patients with life expectancy <3 months or severe functional status impairment (ASA 4)
Patients with hypovascular metastasis documented by angiography or MRI perfusion study with MDC.
Patients with coagulation deficiency or plateletopenic patients.
Patients with documented active infection.

Interested in this trial?

Get notified about updates and connect with the research team.